Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Rask Hamm

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|October 16, 2023
Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort studySebastian Rask Hamm, Sunil Kumar Saini, Annemette Hald, et al.
Vaccines|February 26, 2025
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and InfectionMarita Kern, Sebastian Rask Hamm, Christian Ross Pedersen, et al.
Journal of Internal Medicine|November 29, 2021
Humoral response to two doses of BNT162b2 vaccination in people with HIVLine Dam Heftdal, Andreas Dehlbaek Knudsen, Sebastian Rask Hamm, et al.
Vaccines|October 26, 2024
Post-Transplantation Seroprotection Rates in Liver, Lung, and Heart Transplant Recipients Vaccinated Pre-Transplantation against Hepatitis B Virus and Invasive Pneumococcal DiseaseLise Bank Hornung, Sebastian Rask Hamm, Annemette Hald, et al.
Viruses|January 26, 2024
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid MalignanciesLine Dam Heftdal, Cecilie Bo Hansen, Sebastian Rask Hamm, et al.
Ebiomedicine|June 18, 2023
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort studyLine Dam Heftdal, Laura Pérez-Alós, Rasmus Bo Hasselbalch, et al.
Microbiology Spectrum|March 6, 2023
Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after VaccinationJohannes Roth Madsen, Bettina Eide Holm, Laura Pérez-Alós, et al.
Vaccines|September 27, 2025
Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating PolyneuropathyLouise Sloth Kodal, Sonja Holm-Yildiz, Sebastian Rask Hamm, et al.
Nature Communications|September 12, 2023
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection riskLaura Pérez-Alós, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, et al.
Journal of Internal Medicine|July 8, 2021
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 primingCecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|October 16, 2023
Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort studySebastian Rask Hamm, Sunil Kumar Saini, Annemette Hald, et al.
Vaccines|February 26, 2025
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and InfectionMarita Kern, Sebastian Rask Hamm, Christian Ross Pedersen, et al.
Journal of Internal Medicine|November 29, 2021
Humoral response to two doses of BNT162b2 vaccination in people with HIVLine Dam Heftdal, Andreas Dehlbaek Knudsen, Sebastian Rask Hamm, et al.
Vaccines|October 26, 2024
Post-Transplantation Seroprotection Rates in Liver, Lung, and Heart Transplant Recipients Vaccinated Pre-Transplantation against Hepatitis B Virus and Invasive Pneumococcal DiseaseLise Bank Hornung, Sebastian Rask Hamm, Annemette Hald, et al.
Viruses|January 26, 2024
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid MalignanciesLine Dam Heftdal, Cecilie Bo Hansen, Sebastian Rask Hamm, et al.
Ebiomedicine|June 18, 2023
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort studyLine Dam Heftdal, Laura Pérez-Alós, Rasmus Bo Hasselbalch, et al.
Microbiology Spectrum|March 6, 2023
Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after VaccinationJohannes Roth Madsen, Bettina Eide Holm, Laura Pérez-Alós, et al.
Vaccines|September 27, 2025
Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating PolyneuropathyLouise Sloth Kodal, Sonja Holm-Yildiz, Sebastian Rask Hamm, et al.
Nature Communications|September 12, 2023
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection riskLaura Pérez-Alós, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, et al.
Journal of Internal Medicine|July 8, 2021
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 primingCecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, et al.
Pageof 3